Tag: ASCO 2026

Rick Pazdur speaking at ASCO 2026 conference about FDA restructuring and regulatory competition
Health PolicyPolicy & Systems

FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing China competition as key driver for reform. Speaking…

By
GMJ Policy Desk
Medical infographic showing GLP-1 medication reducing breast cancer risk statistics
Clinical UpdatesNew StudiesPracticeResearch Digest

GLP-1 Weight-Loss Drugs Reduce Breast Cancer Risk by 17% in Largest Study to Date

New research from ASCO 2026 shows GLP-1 weight-loss medications reduce breast cancer risk by 17% and cancer mortality by 24%…

By
GMJ Practice Desk
Medical illustration of bispecific antibody targeting cancer cells
Clinical UpdatesNew StudiesPracticeResearch Digest

BioNTech-Pfizer Bispecific Antibody Shows Promise in Advanced Lung Cancer at ASCO 2026

BioNTech and Pfizer's experimental bispecific antibody BNT327 showed promising activity in advanced lung cancer patients at ASCO 2026. The dual-pathway…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →